Cargando…
Cisplatin treatment induced interleukin 6 and 8 production alters lung adenocarcinoma cell migration in an oncogenic mutation dependent manner
BACKGROUND: The predominant metastatic site of lung cancer (LC) is the brain. Although outdated, conventional cisplatin treatment is still the main therapeutic approach for patients with advanced non-small cell lung cancer (NSCLC), since targeted therapy that offers better tumor control is not alway...
Autores principales: | Kiss, Edit, Abdelwahab, El Husseiny Mohamed Mahmud, Steib, Anita, Papp, Emoke, Torok, Zsofia, Jakab, Laszlo, Smuk, Gabor, Sarosi, Veronika, Pongracz, Judit Erzsebet |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7238555/ https://www.ncbi.nlm.nih.gov/pubmed/32434541 http://dx.doi.org/10.1186/s12931-020-01389-x |
Ejemplares similares
-
Feasibility study of in vitro drug sensitivity assay of advanced non-small cell lung adenocarcinomas
por: Papp, Emoke, et al.
Publicado: (2020) -
KRAS and EGFR Mutations Differentially Alter ABC Drug Transporter Expression in Cisplatin-Resistant Non-Small Cell Lung Cancer
por: Jaromi, Luca, et al.
Publicado: (2021) -
Alteration in the Wnt microenvironment directly regulates molecular events leading to pulmonary senescence
por: Kovacs, Tamas, et al.
Publicado: (2014) -
Is an Immunosuppressive Microenvironment a Characteristic of Both Intra- and Extraparenchymal Central Nervous Tumors?
por: Soltani, Amina, et al.
Publicado: (2021) -
Activated p53 in the anti-apoptotic milieu of tuberous sclerosis gene mutation induced diseases leads to cell death if thioredoxin reductase is inhibited
por: Abdelwahab, ElHusseiny M. M., et al.
Publicado: (2021)